Fera Pharmaceuticals Strengthens Product Pipeline with Acquisition of Investigational New Drug Published: Jul 21, 2010 NEW YORK--(BUSINESS WIRE)--Fera Pharmaceuticals announces the acquisition of an investigational new drug to treat fungal otitis externa (FOE). Related links BioSpace.com This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news